FISCHER · Healthcare · Medical Devices
Composite scorecard: 33/100 — Quality 46 · Valuation 35 · Momentum 0
| Share price | ₹39.92 |
| Market cap | ₹2,531 Cr |
| P/E ratio | 85.9 |
| P/B ratio | 6.5 |
| ROE | 47.4% |
| ROCE | 12.6% |
| Dividend yield | 0.01% |
| Book value | ₹5.96 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹309 Cr | ₹31 Cr | 14.0% |
| 2025 | ₹111 Cr | ₹1 Cr | 3.0% |
| 2024 | ₹21 Cr | ₹2 Cr | 9.0% |
| 2023 | ₹0 Cr | ₹0 Cr | 11.0% |
| 2022 | — | — | — |
Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Lim